Checkmate Pharmaceuticals Inc. (CMPI): Price and Financial Metrics
CMPI Price/Volume Stats
| Current price | $10.50 | 52-week high | $10.50 |
| Prev. close | $10.48 | 52-week low | $2.00 |
| Day low | $10.48 | Volume | 63,600 |
| Day high | $10.50 | Avg. volume | 142,261 |
| 50-day MA | $7.30 | Dividend yield | N/A |
| 200-day MA | $4.60 | Market Cap | 231.40M |
CMPI Stock Price Chart Interactive Chart >
Checkmate Pharmaceuticals Inc. (CMPI) Company Bio
Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company. It engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. It specializes in the field of CpG oligonucleotides. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA.
CMPI Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 238.71% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -80.33% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...